NIAID Banner Logo Image

Mycobacterium Citations List: September, 2018

Literature Citations

1. Synthesis and Antibacterial/Antitubercular/Antioxidant Activities of Compounds Containing Fluoroquinolone Ring Linked to a 4-Thiazolidinone Moiety. Allaka, T.R., N.K. Katari, V. Banothu, S. Maddela, M. Pal, and J.S. Anireddy. Letters in Drug Design & Discovery, 2018. 15(10): p. 1087-1094. ISI[000442773500008].
[WOS]. TB_09_2018.

2. A Novel Synthesis of 2-Arylbenzimidazoles in Molecular Sieves-MeOH System and Their Antitubercular Activity. Chaturvedi, A.K., A.K. Verma, J.P. Thakur, S. Roy, S. Bhushan Tripathi, B.S. Kumar, S. Khwaja, N.K. Sachan, A. Sharma, D. Chanda, K. Shanker, D. Saikia, and A.S. Negi. Bioorganic & Medicinal Chemistry, 2018. 26(15): p. 4551-4559. PMID[30097361].
[PubMed]. TB_09_2018.

3. Synthesis and Biological Evaluation of Coumarin Clubbed Thiazines Scaffolds as Antimicrobial and Antioxidant. Chauhan, N.B., N.B. Patel, V.M. Patel, and B.M. Mistry. Medicinal Chemistry Research, 2018. 27(9): p. 2141-2149. ISI[000444361800005].
[WOS]. TB_09_2018.

4. Discovery and Development of Novel Salicylate Synthase (MbtI) Furanic Inhibitors as Antitubercular Agents. Chiarelli, L.R., M. Mori, D. Barlocco, G. Beretta, A. Gelain, E. Pini, M. Porcino, G. Mori, G. Stelitano, L. Costantino, M. Lapillo, D. Bonanni, G. Poli, T. Tuccinardi, S. Villa, and F. Meneghetti. European Journal of Medicinal Chemistry, 2018. 155: p. 754-763. PMID[29940465].
[PubMed]. TB_09_2018.

5. Ambroxol Induces Autophagy and Potentiates Rifampin Antimycobacterial Activity. Choi, S.W., Y. Gu, R.S. Peters, P. Salgame, J.J. Ellner, G.S. Timmins, and V. Deretic. Antimicrobial Agents and Chemotherapy, 2018. 62(9). e01019-18. PMID[30012752]. PMCID[PMC6125555].
[PubMed]. TB_09_2018.

6. IMB-SD62, a Triazolothiadiazoles Derivative with Promising Action against Tuberculosis. Deng, Q., J. Meng, Y. Liu, Y. Guan, and C. Xiao. Tuberculosis, 2018. 112: p. 37-44. PMID[30205967].
[PubMed]. TB_09_2018.

7. Benzo[d]thiazole-2-carbanilides as new anti-TB Chemotypes: Design, Synthesis, Biological Evaluation, and Structure-Activity Relationship. Dhameliya, T.M., R. Tiwari, A. Banerjee, S. Pancholia, D. Sriram, D. Panda, and A.K. Chakraborti. European Journal of Medicinal Chemistry, 2018. 155: p. 364-380. PMID[29902722].
[PubMed]. TB_09_2018.

8. A katG S315T or an ahpC Promoter Mutation Mediate Mycobacterium tuberculosis Resistance to 2-Thiophen carboxylic acid hydrazide, an Inhibitor Resembling the Anti-tubercular Drugs Isoniazid and Ethionamide. Franceschelli, J.J., J.M. Belardinelli, P. Tong, B. Loftus, A. Recio-Balsells, G.R. Labadie, S.V. Gordon, and H.R. Morbidoni. Tuberculosis, 2018. 112: p. 69-78. PMID[30205971].
[PubMed]. TB_09_2018.

9. Characterization of Mutations Conferring Resistance to Rifampin in Mycobacterium tuberculosis Clinical Strains. Jagielski, T., Z. Bakula, A. Brzostek, A. Minias, R. Stachowiak, J. Kalita, A. Napiorkowska, E. Augustynowicz-Kopec, A. Zaczek, E. Vasiliauskiene, J. Bielecki, and J. Dziadek. Antimicrobial Agents and Chemotherapy, 2018. 62(10): e01093-18. PMID[30061294]. PMCID[PMC6153850].
[PubMed]. TB_09_2018.

10. Design and Evaluation of Biological Activities of 1,3-Oxazolidinone Derivatives Bearing Amide, Sulfonamide, and Thiourea Moieties. Karaman, N., R. Adil Zainel, H.A. Kapkac, H. Karaca Gencer, S. Ilgin, A.B. Karaduman, A. Karakucuk-Iyidogan, E.E. Oruc-Emre, and B. Kocyigit-Kaymakcioglu. Archiv der Pharmazie, 2018. 351(9): e1800057. PMID[30079557].
[PubMed]. TB_09_2018.

11. Synthesis of Carbohydrazides and Carboxamides as Anti-tubercular Agents. Kumar, G., V.S. Krishna, D. Sriram, and S.M. Jachak. European Journal of Medicinal Chemistry, 2018. 156: p. 871-884. PMID[30056283].
[PubMed]. TB_09_2018.

12. In Vitro MIC Values of Rifampin and Ethambutol and Treatment Outcome in Mycobacterium avium Complex Lung Disease. Kwon, B.S., M.N. Kim, H. Sung, Y. Koh, W.S. Kim, J.W. Song, Y.M. Oh, S.D. Lee, S.W. Lee, J.S. Lee, C.M. Lim, C.M. Choi, J.W. Huh, S.B. Hong, S. Park, T.S. Shim, Y.P. Chong, and K.W. Jo. Antimicrobial Agents and Chemotherapy, 2018. 62(10): e00491-18. PMID[30012759]. PMCID[PMC6153803].
[PubMed]. TB_09_2018.

13. Chemical Composition and Biological Activities of the Essential Oil from Cleome rutidosperma DC. McNeil, M.J., R.B.R. Porter, L. Rainford, O. Dunbar, S. Francis, N. Laurieri, and R. Delgoda. Fitoterapia, 2018. 129: p. 191-197. PMID[29981873].
[PubMed]. TB_09_2018.

14. The EU Approved Antimalarial Pyronaridine Shows Antitubercular Activity and Synergy with Rifampicin, Targeting RNA Polymerase. Mori, G., B.S. Orena, C. Franch, L.A. Mitchenall, A.A. Godbole, L. Rodrigues, C. Aguilar-Perez, J. Zemanova, S. Huszar, M. Forbak, T.R. Lane, M. Sabbah, N. Deboosere, R. Frita, A. Vandeputte, E. Hoffmann, R. Russo, N. Connell, C. Veilleux, R.K. Jha, P. Kumar, J.S. Freundlich, P. Brodin, J.A. Ainsa, V. Nagaraja, A. Maxwell, K. Mikusova, M.R. Pasca, and S. Ekins. Tuberculosis, 2018. 112: p. 98-109. PMID[30205975].
[PubMed]. TB_09_2018.

15. Structure-based Drug Design and Characterization of Sulfonyl-piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis. Piton, J., A. Vocat, A. Lupien, C.S. Foo, O. Riabova, V. Makarov, and S.T. Cole. Antimicrobial Agents and Chemotherapy, 2018. 62(10): e00681-18. PMID[30012754]. PMCID[PMC6153800].
[PubMed]. TB_09_2018.

16. Insights into Mycobacterial Activity and Cytotoxicity of Substitued Isoxazole-4-carbohydrazide Derivatives. Ploszaj, P., A. Junka, B. Szponar , M. Maczynski, S. Ryng, M. Bartoszewicz, and A. Piwowar. Acta Poloniae Pharmaceutica, 2018. 75(3): p. 637-647. ISI[000444460300007].
[WOS]. TB_09_2018.

17. Antimycobacterial Activity of Cinnamaldehyde in a Mycobacterium tuberculosis (H37Ra) Model. Sawicki, R., J. Golus, A. Przekora, A. Ludwiczuk, E. Sieniawska, and G. Ginalska. Molecules, 2018. 23(9): E2381. PMID[30231479].
[PubMed]. TB_09_2018.

18. Synthesis and Biological Evaluation of 2-Azetidinone and Thiazolidine-4-one Derivatives Containing Dibenzothiazepine Nucleus. Tailor, J.H., S.K. Zadafiya, G. Malik, and D. Rajani. Indian Journal of Chemistry Section B-Organic Chemistry Including Medicinal Chemistry, 2018. 57(8): p. 1051-1059. ISI[000444361800005].
[WOS]. TB_09_2018.

19. Characterization of New, Efficient Mycobacterium tuberculosis Topoisomerase-I Inhibitors and Their Interaction with Human ABC Multidrug Transporters. Temesszentandrasi-Ambrus, C., S. Toth, R. Verma, P. Banhegyi, I. Szabadkai, F. Baska, C. Szantai-Kis, R.C. Hartkoorn, M.A. Lingerfelt, B. Sarkadi, G. Szakacs, L. Orfi, V. Nagaraja, S. Ekins, and A. Telbisz. Plos One, 2018. 13(9): e0202749. PMID[30183750]. PMCID[PMC6124754].
[PubMed]. TB_09_2018.

20. Synthesis and Evaluation of Nitrofuranyl methyl N-heterocycles Derivatives as Novel Antitubercular Agents. Wang, A., W. Li, B. Wang, K. Lv, H. Wang, M. Liu, H. Guo, and Y. Lu. Future Medicinal Chemistry, 2018. 10(17): p. 2059-2068. PMID[29992836].
[PubMed]. TB_09_2018.

21. Design, Synthesis and Antimicrobial Evaluation of Propylene-tethered Ciprofloxacin-Isatin Hybrids. Wang, R., X. Yin, Y. Zhang, and W. Yan. European Journal of Medicinal Chemistry, 2018. 156: p. 580-586. PMID[30025351].
[PubMed]. TB_09_2018.

22. Tetraethylene Glycol Tethered Heteronuclear bis-Isatin Derivatives: Design, Synthesis, and in Vitro Anti-mycobacterial Activities. Zhao, S., Y. Xu, J. Guan, S. Zhao, G. Zhang, and Z. Xu. Journal of Heterocyclic Chemistry, 2018. 55(9): p. 2172-2177. ISI[000444416900020].
[WOS]. TB_09_2018.

23. Design, Synthesis and Evaluation of N-Pyrazinylbenzamides as Potential Antimycobacterial Agents. Zitko, J., A. Mindlova, O. Valasek, O. Jand'ourek, P. Paterova, J. Janousek, K. Konecna, and M. Dolezal. Molecules, 2018. 23(9): E2390. PMID[30231544].
[PubMed]. TB_09_2018.

Patent Citations

24. Oxadiazole and Phenol Derivatives as Antibacterial and/or Herbicidal Agents. Hagen, T.J., M. Thompson, J.R. Troxell, and B.E. Hartnett. Patent. 2018. 2018-15933608 20180271098: 69pp.
[Patent]. TB_09_2018.

Database last updated: September 2018